Dapagliflozin improves angiogenesis after hindlimb ischemia through the pi3k-akt-enos pathway

HIGHLIGHTS

  • What: This study provided a new perspective new ideas and a theoretical basis for the treatment of peripheral arterial disease. The aim of this study was to investigate the effect and mechanism of dapagliflozin on angiogenesis after hindlimb ischemia .
  • Who: Li Han et al. from the Department of Geriatrics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine have published the research: Dapagliflozin Improves Angiogenesis after Hindlimb Ischemia through the PI3K-Akt-eNOS Pathway, in the Journal: Biomolecules 2024, 14, 592. https:// of 24/03/2024
  • How: The results showed that . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?